P2/N95 respirators &amp; surgical masks to prevent SARS-CoV-2 infection: Effectiveness &amp; adverse effects

Kunstler, Breanne; Newton, Skye; Hill, Hayley; Ferguson, John; Hore, Phillipa; Mitchell, Brett G; Dempsey, Kathy; Stewardson, Andrew J.; Friedman, Deborah; Cole, Kate; Sim, Malcolm Ross; Ferguson, Bridget; Burns, Penelope; King, Nicole; McGloughlin, Steven; Dicks, Melanie; McCarthy, Sally; Tam, B. S.M.; Hazelton, Briony; McGurgan, Cherylynn; McDonald, Steve; Turner, Tari

doi:10.1016/j.idh.2022.01.001

Cited by 25 publications

(46 citation statements)

References 49 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A couple of reviews suggest facemask use may result in a reduction of risk of SARS‐CoV‐2 or other coronavirus infection, with N95 respirators or equivalent having stronger associations than surgical masks in one study 35,170 . Conversely, a more recent review comparing the effectiveness of P2 respirators and surgical masks in preventing SARS‐CoV‐2 infection found insufficient epidemiological evidence to reach a conclusion 171 . Similarly, the Australian National COVID‐19 Clinical Evidence Taskforce found limited epidemiological evidence around the effectiveness of various types of face masks/respirators in protecting HCW from COVID‐19 or similar viruses 15…”

Section: Resultsmentioning

confidence: 99%

“…35,170 Conversely, a more recent review comparing the effectiveness of P2 respirators and surgical masks in preventing SARS-CoV-2 infection found insufficient epidemiological evidence to reach a conclusion. 171 Similarly, the Australian National COVID-19 Clinical Evidence Taskforce found limited epidemiological evidence around the effectiveness of various types of face masks/respirators in protecting HCW from COVID-19 or similar viruses. 15 Despite the limited direct evidence, the Australian National COVID-19 Clinical Evidence Taskforce do recommend the use of P2 masks for HCWs where there is a likely high risk of transmission of SARS-CoV-2.…”

Section: Key Messagementioning

confidence: 99%

See 1 more Smart Citation

Pulmonary function testing during SARS‐CoV‐2: An ANZSRS/TSANZ position statement

Borg

Osadnik

Adam³

et al. 2022

Respirology

View full text Add to dashboard Cite

The Thoracic Society of Australia and New Zealand (TSANZ) and the Australian and New Zealand Society of Respiratory Science (ANZSRS) commissioned a joint position paper on pulmonary function testing during coronavirus disease 2019 (COVID‐19) in July 2021. A working group was formed via an expression of interest to members of both organizations and commenced work in September 2021. A rapid review of the literature was undertaken, with a ‘best evidence synthesis’ approach taken to answer the research questions formed. This allowed the working group to accept findings of prior relevant reviews or societal document where appropriate. The advice provided is for providers of pulmonary function tests across all settings. The advice is intended to supplement local infection prevention and state, territory or national directives. The working group's key messages reflect a precautionary approach to protect the safety of both healthcare workers (HCWs) and patients in a rapidly changing environment. The decision on strategies employed may vary depending on local transmission and practice environment. The advice is likely to require review as evidence grows and the COVID‐19 pandemic evolves. While this position statement was contextualized specifically to the COVID‐19 pandemic, the working group strongly advocates that any changes to clinical/laboratory practice, made in the interest of optimizing the safety and well‐being of HCWs and patients involved in pulmonary function testing, are carefully considered in light of their potential for ongoing use to reduce transmission of other droplet and/or aerosol borne diseases.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Key Messagementioning

confidence: 99%

Pulmonary function testing during SARS‐CoV‐2: An ANZSRS/TSANZ position statement

Borg

Osadnik

Adam³

et al. 2022

Respirology

View full text Add to dashboard Cite

show abstract

“…Health care workers (HCWs) are at increased risk for acquiring SARS-CoV-2 infection, 1 raising the issue of adequate protective measures. Although scientific evidence regarding the benefit of respirator vs surgical masks is sparse, 2,3 a previous study has suggested that respirator masks (ie, FFP2) may offer additional protection to HCW with frequent COVID-19-patient exposure. 4 In this follow-up study, we analyzed the SARS-CoV-2 risk for HCWs depending on cumulative exposure to patients with COVID-19 and assessed whether this risk can be modulated by the use of respirator compared with surgical masks.…”

Section: Introductionmentioning

confidence: 99%

Risk of SARS-CoV-2 Acquisition in Health Care Workers According to Cumulative Patient Exposure and Preferred Mask Type

et al. 2022

View full text Add to dashboard Cite

show abstract

“…La enfermedad por coronavirus (COVID-19) es un síndrome respiratorio agudo grave que fue declarado pandemia mundial en marzo de 2020. El COVID-19 es causado por el coronavirus SARS-CoV-2, este virus se trasmite cuando una persona infectada exhala partículas respiratorias mediante su boca o nariz y son inhaladas por otras personas a través de sus ojos, nariz o boca (1,2). Para prevenir la trasmisión del SARS-CoV-2 se recomiendan un conjunto de medidas de prevención, como el adecuado uso del equipo de protección personal, incluido el uso de la mascarilla quirúrgica o respirador P2/N95 (1,3,4).…”

Section: Introductionunclassified

“…El COVID-19 es causado por el coronavirus SARS-CoV-2, este virus se trasmite cuando una persona infectada exhala partículas respiratorias mediante su boca o nariz y son inhaladas por otras personas a través de sus ojos, nariz o boca (1,2). Para prevenir la trasmisión del SARS-CoV-2 se recomiendan un conjunto de medidas de prevención, como el adecuado uso del equipo de protección personal, incluido el uso de la mascarilla quirúrgica o respirador P2/N95 (1,3,4). Sin embargo, durante la anterior pandemia del síndrome respiratorio agudo severo de 2002-2004, se informaron reacciones cutáneas adversas después de un uso prolongado de respiradores N95 como acné, picor facial, urticaria y dermatitis alérgica de contacto (5)(6)(7).…”

Section: Introductionunclassified

Dermatitis alérgica de contacto asociada al uso de la mascarilla durante la pandemia por SARS-CoV-2

Ayala

Gámez

2022

View full text Add to dashboard Cite

Introducción: El uso de mascarilla personal por parte del personal de salud y población en general es necesario durante la pandemia por COVID-19, sin embargo, ha resultado en un aumento significativo de la prevalencia dermatitis de contacto alérgica, dermatitis de contacto irritante, dermatitis seborreica, urticaria de contacto y exacerbación del acné y las infecciones de la piel. Metodología: revisión no sistemática sobre la dermatitis alérgica de contacto asociada al uso de mascarillas y respiradores N95 durante la pandemia por COVID 19, se emplearon los términos y descriptores “dermatitis and mask” y “dermatitis and Covid-19” en las bases de datos ScienDirect, Pubmed, SciELO y Redalyc; se consideró trabajos publicados en idioma español y/o inglés, de vigencia no mayor a 5 años. Resultados: El uso de la mascarilla por un periodo superior a 6 horas ha demostrado incrementar la incidencia de dermatitis alérgica, presentado lesiones principalmente en mejillas, dorso de la nariz, frente y zona retroauricular. Conclusiones: Esta es una entidad patológica presumiblemente de gran incidencia y subdiagnóstico. Constituye una forma de hipersensibilidad tipo IV, que de no ser tratada a tiempo puede devenir en complicaciones asociadas a sobreinfección; el personal sanitario y la comunidad en general debe ser educado en medidas de prevención de este tipo de lesiones y orientarlos para buscar atención médica oportuna de ser necesario.

show abstract

P2/N95 respirators & surgical masks to prevent SARS-CoV-2 infection: Effectiveness & adverse effects

Cited by 25 publications

References 49 publications

Pulmonary function testing during SARS‐CoV‐2: An ANZSRS/TSANZ position statement

Pulmonary function testing during SARS‐CoV‐2: An ANZSRS/TSANZ position statement

Risk of SARS-CoV-2 Acquisition in Health Care Workers According to Cumulative Patient Exposure and Preferred Mask Type

Dermatitis alérgica de contacto asociada al uso de la mascarilla durante la pandemia por SARS-CoV-2

Contact Info

Product

Resources

About